Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH plus low-dose aspirin vs low-dose aspirin for prevention of recurrent preeclampsia
2008-005705-19Phase 3Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin, aspirin in preeclampsia, intrauterine growth restriction (IUGR), low birth weight (LBW), sponsored by Policlinico Gemelli. Started Oct 2008; status: terminated.
02
Drugs
enoxaparinaspirin
03
Conditions
preeclampsiaintrauterine growth restriction (IUGR)low birth weight (LBW)
Beyond the preview
Go deeper on 2008-005705-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005705-19.